Bristol-Myers Squibb - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

All Categories ... by Company » ... Bristol-Myers Squibb

Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition

Condition: Type 2 Diabetes
Intervention: Drug: Metformin
Sponsor: Torrent Pharmaceuticals Limited
Completed - verified March 2010
Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.

Condition: Type 2 Diabetes
Intervention: Drug: Metformin
Sponsor: Torrent Pharmaceuticals Limited
Completed - verified March 2010
Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions.

Condition: Type 2 Diabetes
Intervention: Drug: Metformin
Sponsor: Torrent Pharmaceuticals Limited
Completed - verified March 2010
Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions.

Condition: Type 2 Diabetes
Intervention: Drug: Metformin
Sponsor: Torrent Pharmaceuticals Limited
Completed - verified March 2010
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

Condition: Rheumatoid Arthritis
Intervention: Other: Observational Study
Sponsor: Bristol-Myers Squibb
Active, not recruiting - verified March 2010
Abatacept Pregnancy Exposure Registry

Condition: Rheumatoid Arthritis
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; University of California, San Diego; Organization of Teratology Information Specialists (OTIS)
Active, not recruiting - verified March 2010
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

Condition: Rheumatoid Arthritis
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; National Data Bank for Rheumatic Diseases
Active, not recruiting - verified March 2010
Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer

Condition: Colorectal Cancer
Interventions: Drug: BMS-908662; Drug: BMS-908662; Drug: Cetuximab
Sponsors: Bristol-Myers Squibb; Genzyme
Not yet recruiting - verified March 2010
Risk of Cardiovascular Events in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Risk of Acute Kidney Injury and Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment

Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

Conditions: Atherosclerosis; Hypercholesterolemia
Interventions: Drug: BMS-844421; Drug: 0.9% sodium chloride injection solution
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Condition: Chronic Hepatitis B Virus, Pediatric
Interventions: Drug: Entecavir; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163

Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163; Drug: BMS-708163; Drug: Placebo; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
Screening DIVA - Diffuse Vascular Disease

Condition: Peripheral Vascular Diseases
Intervention:
Sponsors: Sanofi-Aventis; Bristol-Myers Squibb
Recruiting - verified February 2010
A Study to to Assess the Effect of Dapagliflozin When Administered Once a Day Versus Twice a Day on Blood Glucose

Condition: Healthy Volunteers
Interventions: Drug: Dapagliflozin; Drug: Dapagliflozin
Sponsors: AstraZeneca; Bristol-Myers Squibb
Active, not recruiting - verified March 2010

Bristol-Myers Squibb - Database of Clinical Trials by Pharmaceutical Companies - Clinical Trials

Bristol-Myers Squibb - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups by Category

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials